Search

Your search keyword '"Van Den Berg, Leonard"' showing total 1,604 results

Search Constraints

Start Over You searched for: Author "Van Den Berg, Leonard" Remove constraint Author: "Van Den Berg, Leonard" Language english Remove constraint Language: english
1,604 results on '"Van Den Berg, Leonard"'

Search Results

1. Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids

3. ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes

4. Author Correction: The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration

6. Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data

7. Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study

8. Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

11. Comprehensive evaluation of smoking exposures and their interactions on DNA methylation

14. A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial

17. The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases

19. Whole genome sequencing analysis reveals post-zygotic mutation variability in monozygotic twins discordant for amyotrophic lateral sclerosis

23. Whole-genome sequencing reveals that variants in the Interleukin 18 Receptor Accessory Protein 3′UTR protect against ALS

24. Genetic variants associated with longitudinal changes in brain structure across the lifespan

25. REVEALS—a longitudinal cohort study of multifaceted respiratory assessment in ALS.

26. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility

27. Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis

28. The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration

29. Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial

30. Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1

31. Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial

32. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

36. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

46. Validated inference of smoking habits from blood with a finite DNA methylation marker set

49. KIF1A variants are a frequent cause of autosomal dominant hereditary spastic paraplegia

50. Validating biomarkers and models for epigenetic inference of alcohol consumption from blood

Catalog

Books, media, physical & digital resources